M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma

BACKGROUND: Myxoma virus (MYXV) is a promising oncolytic agent and is highly effective against immortalized glioma cells but less effective against brain tumor initiating cells (BTICs), which are believed to mediate glioma development/recurrence. MYXV encodes various proteins to attenuate host cell...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Pisklakova, Alexandra, McKenzie, Brienne, Zemp, Franz, Lun, Xueqing, Kenchappa, Rajappa S., Etame, Arnold B., Rahman, Masmudur M., Reilly, Karlyne, Pilon-Thomas, Shari, McFadden, Grant, Kurz, Ebba, Forsyth, Peter A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2016
Gaiak:
Basic and Translational Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933479/
https://ncbi.nlm.nih.gov/pubmed/26962017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak